SYN-Tech Chem & Pharm Co Ltd Total Liabilities
SYN-Tech Chem & Pharm Co Ltd total liabilities. Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) has total liabilities worth NT$369.57 Million TWD (≈ $11.64 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are SYN-Tech Chem & Pharm Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of SYN-Tech Chem & Pharm Co Ltd (2015–2025)
Total liabilities of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025. This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of SYN-Tech Chem & Pharm Co Ltd to see how much of total assets are deployed in long-term investments.
SYN-Tech Chem & Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of SYN-Tech Chem & Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Excel Cell Electronic Co Ltd
TW:2483
|
Taiwan | NT$1.72 Billion |
|
Reward Wool Industry Corp
TW:1423
|
Taiwan | NT$246.56 Million |
|
Falco Resources Ltd
V:FPC
|
Canada | CA$112.79 Million |
|
Panache Digilife Limited
NSE:PANACHE
|
India | Rs590.05 Million |
|
Top Union Electronics
TWO:6266
|
Taiwan | NT$1.32 Billion |
|
ADDvise Group B
ST:ADDV-B
|
Sweden | Skr1.81 Billion |
|
Graphite One Inc
V:GPH
|
Canada | CA$3.66 Million |
|
Singular People S.A.
MC:SNG
|
Spain | €43.61 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down SYN-Tech Chem & Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SYN-Tech Chem & Pharm Co Ltd assets under control.
Liquidity & Leverage Metrics
SYN-Tech Chem & Pharm Co Ltd Total Liabilities Ratios Explained
SYN-Tech Chem & Pharm Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SYN-Tech Chem & Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SYN-Tech Chem & Pharm Co Ltd (2015–2025)
The table below shows the annual total liabilities of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$369.57 Million ≈ $11.64 Million |
+26.72% |
| 2024-12-31 | NT$291.65 Million ≈ $9.19 Million |
-50.02% |
| 2023-12-31 | NT$583.48 Million ≈ $18.38 Million |
+0.58% |
| 2022-12-31 | NT$580.13 Million ≈ $18.28 Million |
-36.37% |
| 2021-12-31 | NT$911.71 Million ≈ $28.72 Million |
+68.38% |
| 2020-12-31 | NT$541.46 Million ≈ $17.06 Million |
-22.75% |
| 2019-12-31 | NT$700.89 Million ≈ $22.08 Million |
-3.44% |
| 2018-12-31 | NT$725.85 Million ≈ $22.87 Million |
+29.70% |
| 2017-12-31 | NT$559.62 Million ≈ $17.63 Million |
+115.30% |
| 2016-12-31 | NT$259.92 Million ≈ $8.19 Million |
+1.88% |
| 2015-12-31 | NT$255.12 Million ≈ $8.04 Million |
-- |
About SYN-Tech Chem & Pharm Co Ltd
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more